ZVSA
USDZyVersa Therapeutics Inc. Common Stock
$0.145+0.009 (6.618%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$0.136
Haut
$0.145
Bas
$0.136
Volume
0.00M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.2M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.04M
Bourse
OQB
Devise
USD
Intervalle sur 52 Semaines
Bas $0.11Actuel $0.145Haut $1.95
Actualités Connexes
GlobeNewswire
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.Cardiovascular
Voir plus
GlobeNewswire
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys' filtration system. VAR 200 directly removes lipids from kidney cells,
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.